ROCHESTER, Mich. , May 24, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that management will participate in the 42 nd Annual William Blair Growth Stock
ROCHESTER, Mich. , May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy today announced that Mike Rousselle , vice president of data product, has been named one of the
ROCHESTER, Mich. , May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that its Board of Directors has unanimously authorized a share repurchase
ROCHESTER, Mich. , May 10, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that management will participate in the RBC Healthcare Conference taking place
Revenue Up 22% to $13.7 million on increased average revenue per top 20 pharmaceutical manufacturer client Traction with top 20 pharmaceutical manufacturers continues to advance and drive growth Cash flow positive from operations of $4.1 million ROCHESTER, Mich.
ROCHESTER, Mich. , April 29, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy has published its first Environmental, Social and Governance (ESG) report .
ROCHESTER, Mich. , April 21, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, will hold a conference call on Wednesday, May 4, 2022, at 4:30 p.m.
Physicians report that medication access impacts initial therapy choice for some patients and may require changes to preferred treatment plan ROCHESTER, Mich. , April 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology
OptimizeRx grew 2021 revenue by 42% year-over-year, spotlighting the rapid growth from the convergence of technology and healthcare ROCHESTER, Mich. , April 05, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions
OptimizeRx expands reach of its point-of-care solutions to simplify the prescribing process of specialty medications for healthcare providers, and to enable greater access for patients ROCHESTER, Mich. , March 15, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading
